Polypeptides IGF-1C and P24 synergistically promote osteogenic differentiation of bone marrow mesenchymal stem cells in vitro through the p38 and JNK signaling pathways
- 1 December 2021
- journal article
- research article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 141, 106091
Abstract
No abstract availableKeywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Clinical Trials with Mesenchymal Stem Cells: An UpdateCell Transplantation, 2016
- Anabolic effects of IGF-1 signaling on the skeletonFrontiers in Endocrinology, 2013
- Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiationActa Biomaterialia, 2012
- Bone induction through controlled release of novel BMP-2-related peptide from PTMC 11 -F127-PTMC 11 hydrogelsBiomedical Materials, 2012
- In vitro cellular responses to scaffolds containing two microencapulated growth factorsBiomaterials, 2009
- IGF-I regulates tight-junction protein claudin-1 during differentiation of osteoblast-like MC3T3-E1 cells via a MAP-kinase pathwayCell and tissue research, 2008
- BMP-2/4 and BMP-6/7 Differentially Utilize Cell Surface Receptors to Induce Osteoblastic Differentiation of Human Bone Marrow-derived Mesenchymal Stem CellsJournal of Biological Chemistry, 2008
- BMP-2 and Insulin-like Growth Factor-I Mediate Osterix (Osx) Expression in Human Mesenchymal Stem Cells via the MAPK and Protein Kinase D Signaling PathwaysJournal of Biological Chemistry, 2005
- Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signalingJournal of Cellular Biochemistry, 2005
- Circulating levels of IGF-1 directly regulate bone growth and densityJournal of Clinical Investigation, 2002